Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
Pozycja w akcjach #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
Cena akcji
$1.84
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$66.03M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-8.25%
Kraj
ES
Handel Pangaea Oncology, S.A. (PANG)

Kategoria

Historia ceny akcji dla Pangaea Oncology, S.A. (PANG)
Najwyższa cena zamknięcia: $1.84 dnia 2026-08-01

Najniższa cena zamknięcia: $2.93 dnia 2017-09-01
Historia cen akcji firmy Pangaea Oncology, S.A. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -2.66%
2025 8.06%
2024 15.26%
2023 2.98%
2022 -25.56%
2021 6.89%
2020 3.56%
2019 -27.13%
2018 -12.00%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US